The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas

被引：0
|
作者：
Rachel Grossman
Michelle A. Rudek
Harry Brastianos
Patti Zadnik
Henry Brem
Betty Tyler
Jaishri O. Blakeley
机构：
[1] Tel-Aviv Medical Center,Department of Neurosurgery
[2] Johns Hopkins University School of Medicine,The Sidney Kimmel Comprehensive Cancer Center
[3] McMaster University,Department of Medicine
[4] Johns Hopkins University School of Medicine,Department of Neurosurgery
[5] Johns Hopkins University School of Medicine,Department of Neurology, Neurosurgery and Oncology
[6] Johns Hopkins University School of Medicine,Department of Neurosurgery, Oncology and Biomedical Engineering
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
Microdialysis; Brain tumor; Angiogenesis; Temozolomide; Bevacizumab; U87 glioma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 139
页数：10
相关论文
共 50 条
  • [1] The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas
    Grossman, Rachel
    Rudek, Michelle A.
    Brastianos, Harry
    Zadnik, Patti
    Brem, Henry
    Tyler, Betty
    Blakeley, Jaishri O.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 129 - 139
  • [2] Comparison of Corticotropin-Releasing Factor, Dexamethasone, and Temozolomide: Treatment Efficacy and Toxicity in U87 and C6 Intracranial Gliomas
    Moroz, Maxim A.
    Huang, Ruimin
    Kochetkov, Tatiana
    Shi, Weiji
    Thaler, Howard
    de Stanchina, Elisa
    Gamez, Idoia
    Ryan, Robert P.
    Blasberg, Ronald G.
    CLINICAL CANCER RESEARCH, 2011, 17 (10) : 3282 - 3292
  • [3] Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells
    Mousavi, Seyed Mojtaba
    Hosseindoost, Saereh
    Mahdian, Seyed Mohammad Amin
    Vousooghi, Nasim
    Rajabi, Ali
    Jafari, Ameneh
    Ostadian, Amirreza
    Hamblin, Michael R.
    Hadjighassem, MahmoudReza
    Mirzaei, Hamed
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 245
  • [4] Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line
    Drljaca, Jovana
    Popovic, Aleksandra
    Bulajic, Dragica
    Stilinovic, Nebojsa
    Vidicevic Novakovic, Sasenka
    Sekulic, Slobodan
    Milenkovic, Ivan
    Ninkovic, Srdan
    Ljubkovic, Marko
    Capo, Ivan
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (09) : 1447 - 1457
  • [5] Focused Ultrasound With Microbubbles Increases Temozolomide Delivery in U87 Transfected Mice
    Deibert, Christopher P.
    Zussman, Benjamin M.
    Engh, Johnathan A.
    NEUROSURGERY, 2015, 76 (04) : N22 - N23
  • [6] Role for Metallothionein-3 in the Resistance of Human U87 Glioblastoma Cells to Temozolomide
    Santangelo, Rosa
    Rizzarelli, Enrico
    Copani, Agata
    ACS OMEGA, 2020, 5 (29): : 17900 - 17907
  • [7] Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma
    Zhang, Wei
    Fulci, Giulia
    Buhrman, Jason S.
    Stemmer-Rachamimov, Anat O.
    Chen, John W.
    Wojtkiewicz, Gregory R.
    Weissleder, Ralph
    Rabkin, Samuel D.
    Martuza, Robert L.
    MOLECULAR THERAPY, 2012, 20 (01) : 37 - 45
  • [8] Current evidence of temozolomide and bevacizumab in treatment of gliomas
    Nanegrungsunk, Danop
    Onchan, Wimrak
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    NEUROLOGICAL RESEARCH, 2015, 37 (02) : 167 - 183
  • [9] EFFICACY OF BEVACIZUMAB ± TEMOZOLOMIDE AGAINST PEDIATRIC GLIOMAS
    Keir, Stephen
    Friedman, Henry
    Bigner, Darell
    NEURO-ONCOLOGY, 2011, 13 : I6 - I6
  • [10] Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis
    Vlachostergios, Panagiotis J.
    Papandreou, Christos N.
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 307 - 310
12345